GPLD1 and cancer: Increased levels of PA and PI in the cancer cohort (evidenced by DESI) also have stimulatory effects on PAK1 activity through the direct binding of PLD-derived PA to PAK1 or through the involvement of PI lipids in signaling pathways that activate PAK1 (65, –67).